**Core Concept**
Flibanserin is a serotonin modulator and stimulator (SMS) that targets the hypothalamic-pituitary-gonadal axis, aiming to restore the balance between serotonin and dopamine in the brain. This action is crucial for addressing the symptoms of hypoactive sexual desire disorder (HSDD) in premenopausal women.

**Why the Correct Answer is Right**
Flibanserin works by inhibiting the reuptake of serotonin and dopamine, increasing the levels of these neurotransmitters in the brain. This leads to an increase in the release of dopamine, which is associated with pleasure and reward, thereby improving sexual desire. The exact mechanism of action is not fully understood, but it is thought to involve the activation of serotonin 5-HT1A and 5-HT3 receptors, as well as the inhibition of serotonin 5-HT2A receptors.

**Why Each Wrong Option is Incorrect**
**Option A:** Flibanserin is not used to treat depression or anxiety disorders, as it is not a traditional antidepressant or anxiolytic medication. While it may have some effects on mood, its primary indication is for HSDD.
**Option B:** Flibanserin is not a hormone replacement therapy (HRT) or a medication for menopausal symptoms. Its mechanism of action is distinct from HRT, which focuses on replacing estrogen and progesterone levels in the body.
**Option C:** Flibanserin is not a medication for erectile dysfunction (ED) or male hypogonadism. While it may have some effects on male sexual function, its primary indication is for HSDD in premenopausal women.

**Clinical Pearl / High-Yield Fact**
Flibanserin is the first FDA-approved medication for HSDD in premenopausal women, and its use highlights the importance of addressing the complex interplay between neurotransmitters and hormones in the treatment of female sexual dysfunction.

**Correct Answer:** C. Hypoactive sexual desire disorder (HSDD) in premenopausal women.